Combined oxidative phosphorylation defect type 15

Combined oxidative phosphorylation defect type 15 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by onset in infancy or early childhood of muscular hypotonia, gait ataxia, mild bilateral pyramidal tract signs, developmental delay (affecting mostly speech and coordination) and subsequent intellectual disability. Short stature, obesity, microcephaly, strabismus, nystagmus, reduced visual acuity, lactic acidosis, and a brain neuropathology consistent with Leigh syndrome are also reported.

Also known as: COXPD15, MTFMT combined oxidative phosphorylation deficiency, combined oxidative phosphorylation defect type 15, combined oxidative phosphorylation deficiency caused by mutation in MTFMT, combined oxidative phosphorylation deficiency type 15, combined oxidative phosphorylation deficiency 15

13 clinical trials for this condition and its sub-types, 0 tagged with Combined oxidative phosphorylation defect type 15 itself.